Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Current Diabetes Reports|August 17, 2015
Vascular Smooth Muscle as a Target for Novel TherapeuticsKaren E Porter, Kirsten RichesClinical Science (London, England : 1979)|May 3, 2013
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Karen E Porter, Kirsten RichesCholesterol|September 20, 2012
Lipoprotein(a): Cellular Effects and Molecular MechanismsKirsten Riches, Karen E PorterDiabetes & Vascular Disease Research|September 5, 2013
Cellular and molecular mechanisms of endothelial dysfunction in diabetesAnna C Roberts, Karen E PorterFibrogenesis & Tissue Repair|March 2, 2013
Function and fate of myofibroblasts after myocardial infarctionNeil A Turner, Karen E PorterExpert Reviews in Molecular Medicine|July 2, 2011
Statins and myocardial remodelling: cell and molecular pathwaysKaren E Porter, Neil A TurnerIUBMB Life|January 5, 2012
Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblastsNeil A Turner, Karen E PorterPharmacology & Therapeutics|May 23, 2009
Cardiac fibroblasts: at the heart of myocardial remodelingKaren E Porter, Neil A TurnerVascular Pharmacology|November 10, 2016
Transendothelial glucose transport is not restricted by extracellular hyperglycaemiaSarka Tumova, Asimina Kerimi, Karen E Porter, et al.Journal of Cardiovascular Pharmacology|December 1, 2007
Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasionNeil A Turner, Lynne Midgley, David J O'Regan, et al.Pageof 10